Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026
April 23, 2026
Calycia Bioscience was awarded the People’s Choice Award at the 2026 Altitude Labs Demo Day. CaLycia is developing engineered macrophage therapies that hone in on solid tumors and alleviate immune suppression, unlocking a broader immune response against some of the hardest targets in oncology. BioUtah congratulates Daniel Greiner and the Calycia Bioscience team!
Recent News
- Collaboration with Quest Diagnostics to expand kidneyintelX.dkd TM testing in the United States
- Utah Business Innovation Awards Summit Recap
- Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
- Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
